Explore

Rapid Read Rapid Read
Burundi Faces Mystery Illness Outbreak with Fatalities and Unidentified Pathogen

Burundi Faces Mystery Illness Outbreak with Fatalities and Unidentified Pathogen

An outbreak of a mystery illness in Burundi has resulted in the deaths of at least five individuals and has sickened 35 others since March 30, marking a case-fatality rate of 14%. The symptoms reported include fever, vomiting, diarrhea, headache, and dark urine, with severe cases showing neurological symptoms, anemia, jaundice, and difficulty breathing. The Africa Centres for Disease Control and Prevention (Africa CDC) has confirmed that tests on patient samples have returned negative for over 200 known pathogens, including Ebola, Marburg virus, Rift Valley fever, yellow fever, and Crimean-Congo hemorrhagic fever. Public health officials are also conducting animal testing to investigate potential zoonotic transmission, which involves pathogens jumping from animals to humans. The World Health Organization (WHO) is assisting Burundi's health ministry in enhancing disease surveillance, field investigation, clinical care, laboratory diagnosis, and infection prevention and control. Samples have been sent to the...
Rapid Read Rapid Read
Scientists Warn of Rising Drug-Resistant Fungi Threatening Agriculture and Health

Scientists Warn of Rising Drug-Resistant Fungi Threatening Agriculture and Health

Scientists are increasingly concerned about the rise of drug-resistant fungi, which pose a significant threat to both agriculture and human health. According to Paul Verweij, a professor of clinical mycology, the widespread use of fungicides in agriculture is contributing to this problem. These fungicides, which are similar to antifungal drugs used in medicine, are leading to resistance in fungi that can affect humans. This resistance is particularly problematic because fungi have cell structures similar to human cells, making it difficult to develop drugs that target fungi without harming human cells. The issue is compounded by the fact that only five classes of antifungal drugs have been developed in the past 75 years, with azoles being the most important. The resistance is spreading globally, with spores traveling long distances through the air, and is particularly challenging in lower-income countries where strict infection control measures are harder to implement.
Rapid Read Rapid Read
Eswatini's Efforts to Eliminate Malaria Amidst Climate and Migration Challenges

Eswatini's Efforts to Eliminate Malaria Amidst Climate and Migration Challenges

Eswatini, formerly known as Swaziland, is intensifying efforts to eliminate malaria despite challenges posed by climate change, economic migration, and insecticide resistance. The country recorded 362 confirmed malaria cases in 2024, while neighboring Mozambique reported 11.6 million cases. The changing climate is extending the malaria season, coinciding with the sugarcane harvest when people are in the fields. The national malaria prevention team is actively conducting surveillance and applying insecticides to prevent outbreaks. Aid cuts have impacted malaria services, but the government is exploring integrated border controls to improve health surveillance.
Trendline Trendline
Co-Diagnostics to Present TB Testing Platform at Washington Summit

Co-Diagnostics to Present TB Testing Platform at Washington Summit

Co-Diagnostics to Present TB Testing Platform at Washington Summit
Rapid Read Rapid Read
Chagas Disease Spread by Kissing Bugs on the Rise in Texas, Affecting Pets and Humans

Chagas Disease Spread by Kissing Bugs on the Rise in Texas, Affecting Pets and Humans

In Texas, a dog owner named Becky Roche has shared her experience of losing her dog, Ranger, to Chagas disease, which is spread by the Triatominae family of insects, commonly known as kissing bugs. These insects are prevalent in 29 U.S. states, and about 50% of them carry the disease. The disease is caused by a parasite that can be transmitted to both dogs and humans through the feces of the kissing bugs. The bugs are most active at night and are often found in gardens and wooded areas. Dr. Ashley Saunders, a veterinary cardiologist, explains that the parasite can cause severe heart damage in dogs, leading to heart failure. The World Health Organization notes that humans can be cured if treated during the acute phase of infection.
Rapid Read Rapid Read
WHO Warns U.S. Aid Cuts and Iran Conflict Threaten African Vaccination Progress

WHO Warns U.S. Aid Cuts and Iran Conflict Threaten African Vaccination Progress

The World Health Organization (WHO) has reported that vaccination programs in Africa have saved millions of lives over the past two decades. However, the organization warns that progress is at risk due to U.S. aid cuts and the ongoing conflict in Iran. The WHO's analysis shows that vaccines have prevented over 4 million deaths annually, with significant achievements such as the eradication of wild poliovirus and the introduction of malaria vaccines in 25 countries. Despite these successes, the COVID-19 pandemic has increased the number of children who have never received a vaccine, and aid cuts under President Trump's 'America First' policy have further strained resources. The U.S. withdrawal from WHO has resulted in a significant loss of funding, and the Iran conflict is disrupting supply chains, affecting health facilities reliant on generators.
Rapid Read Rapid Read
Global Experts Urge Action Against Rising Antifungal Drug Resistance

Global Experts Urge Action Against Rising Antifungal Drug Resistance

Infectious disease experts worldwide are raising alarms over a growing resistance to antifungal drugs, which they describe as a 'silent surge.' This resistance is particularly concerning with pathogens like Candida auris and azole-resistant Aspergillus, which are increasingly found in intensive care units and communities. The experts, led by Paul Verweij from Radboud University Medical Centre, have published a five-step plan in Nature Medicine to address this issue. Their plan aims to influence the World Health Organization's upcoming update to its Global Action Plan on Antimicrobial Resistance (AMR). The proposed measures include raising awareness, improving surveillance, enhancing infection prevention and control, optimizing current antifungal therapies, and increasing investment in new diagnostics and medicines. The experts emphasize the need for support in low- and middle-income countries, where the impact of drug-resistant fungi is particularly severe.
Rapid Read Rapid Read
WHO Reports Vaccination Success in Africa Amid U.S. Aid Cuts and Middle East Conflict

WHO Reports Vaccination Success in Africa Amid U.S. Aid Cuts and Middle East Conflict

The World Health Organization (WHO) has highlighted the success of vaccination programs in Africa, which have saved millions of lives over the past two decades. However, the organization warns that progress is at risk due to U.S. aid cuts and the ongoing conflict in the Middle East. The WHO's comprehensive analysis reveals that over 500 million children have been vaccinated since 2000, preventing more than 4 million deaths annually. Despite these achievements, the COVID-19 pandemic has increased the number of unvaccinated children, and aid cuts under President Trump's 'America First' policy have further strained resources. The U.S. withdrawal from WHO in January resulted in a significant loss of funding, prompting calls for increased domestic health financing in Africa.
1Weather 1Weather
Eswatini's Battle Against Malaria Amid Climate and Migration Challenges

Eswatini's Battle Against Malaria Amid Climate and Migration Challenges

Eswatini, a landlocked nation in southern Africa, is intensifying efforts to eliminate malaria, a disease that remains a significant health challenge due to climate change and migration. The country, formerly known as Swaziland, faces increased malaria transmission as changing weather patterns extend the breeding season for mosquitoes. Informal migration from neighboring countries with higher malaria rates, such as Mozambique, complicates eradication efforts. Eswatini recorded 362 malaria cases in 2024, while Mozambique reported 11.6 million cases. The national malaria program employs various strategies, including mosquito trapping and insecticide testing, to combat the disease. The program also responds rapidly to new cases, deploying teams to affected areas to conduct tests and apply insecticides. Despite challenges like aid cuts and insecticide resistance, Eswatini remains committed to achieving malaria elimination.
AP News AP News
WHO says vaccinations saving millions in Africa, but U.S aid cuts and Iran war threaten progress

WHO says vaccinations saving millions in Africa, but U.S aid cuts and Iran war threaten progress

The World Health Organization says vaccination programs across Africa have saved more than 50 million lives over the past five decades, but progress is slowing in some countries
Rapid Read Rapid Read
ProImmune and University of Texas Medical Branch Collaborate on Infectious Disease Research Using Ankyrons

ProImmune and University of Texas Medical Branch Collaborate on Infectious Disease Research Using Ankyrons

ProImmune, Ltd. has announced a collaboration with the University of Texas Medical Branch (UTMB) to advance research on high-consequence infectious diseases using Ankyrons. These are novel small, single-domain binding reagents that can be rapidly developed for new and emerging disease targets. The collaboration aims to utilize Ankyrons for precise detection and study of viral proteins, which could inform the development of vaccines and treatments. The research will focus on pathogens of global health concern, including various strains of the Ebola virus and the Mpox virus. This partnership leverages ProImmune's Ankyron technology and UTMB's expertise in immunopathology to enhance pandemic preparedness.
Rapid Read Rapid Read
Global Health Experts Warn of Rising Antifungal Resistance Threat

Global Health Experts Warn of Rising Antifungal Resistance Threat

Infectious disease experts worldwide are raising alarms over a growing resistance to antifungal drugs, a concern highlighted in a recent publication in Nature Medicine. Led by Paul Verweij from Radboud University Medical Centre, the group of over 50 researchers is advocating for the inclusion of antifungal resistance in global antimicrobial resistance (AMR) strategies, which have traditionally focused on bacterial and viral infections. The experts have proposed a five-step plan to address this issue, emphasizing the need for increased awareness, improved surveillance, and investment in new diagnostics and treatments. The rise of drug-resistant fungi, such as Candida auris and Aspergillus fumigatus, poses significant health risks, particularly in vulnerable populations. The experts warn that without integrating antifungal resistance into the 2026 Global Action Plan on AMR, the world risks repeating past mistakes made with antibacterial resistance.